The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Newly Discovered Molecule Modulates Cartilage Repair

Newly Discovered Molecule Modulates Cartilage Repair

August 29, 2012 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Destruction of articular cartilage is often degenerative and leads to osteoarthritis (OA). Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.1

You Might Also Like
  • New Methodology to Improve Cartilage Repair
  • Telomere Length Provides Insights into Cartilage Aging and Repair
  • Mesenchymal Stem Cell Therapy May Help Slow, Repair Degenerative Signs of Osteoarthritis, Musculoskeletal Disease
Also By This Author
  • Tocilizumab Is Effective to Treat GCA

“This is very early-stage research, and much more scientific research needs to be accomplished,” said Kristen Johnson, PhD, of the Genomics Institute of the Novartis Research Foundation in an e-mail to The Rheumatologist. “Kartogenin was discovered from a screen to look for compounds that promote the differentiation of endogenous stem cells into chondrocytes. The number of the stem cells in cartilage increase in an injury. In a mouse model, addition of kartogenin after an injury resulted in appearance of more chondrocytes and matrix proteins and restoration of hyaline articular cartilage.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The small molecule, kartogenin, was identified by the use of an image-based high-throughput screen of primary human bone marrow multipotent mesenchymal stem cells (MSCs). Kartogenin was subsequently evaluated on articular chondrocytes and found to both promote the selective differentiation of MSCs and be chondroprotective.

Pathophysiological tests revealed kartogenin to also be chondroprotective in two OA animal models. Specifically, kartogenin treatment resulted in a 50% reduction in joint score in an acute surgical model of OA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A focused structure–activity relationship study suggested that kartogenin induces MSC differentiation via an association with filamin A (FLNA). FLNA regulates cytoskeletal network organization and dynamics by binding to and cross-linking actin. Kartogenin further induces chondrogenesis by regulating the interaction of the transcription factor core-binding factor β subunit (CBFβ) with its target.

In the resting state, CBFβ is bound to its cytoplasmic partner, FLNA, and is sequestered in the cytoplasm. Upon activation, it dissociates from FLNA, translocates into the nucleus, and binds the runt-related transcription factor (RUNX) family members, thereby regulating transcription. RUNX proteins are highly regulated by complex signaling networks in a way that correlates with their distinct roles in musculoskeletal development and maintenance. RUNX proteins therefore represent an intriguing target for OA drug development.

Dr. Johnson explained the future directions of her research, “Within Novartis Institutes for Biomedical Research, we are actively working to gain further understanding of how kartogenin functions and to determine the appropriate clinical indication to which it is best suited. Due to the very early-stage nature of this research, it is hard to predict timing of clinical entry or long-term outcome. However, we are working diligently on this program, and preclinical studies suggest we are moving in the right direction to help patients and address unmet medical need.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Osteoarthritis, Research Reviews Tagged With: cartilage, Osteoarthritis, Research

You Might Also Like:
  • New Methodology to Improve Cartilage Repair
  • Telomere Length Provides Insights into Cartilage Aging and Repair
  • Mesenchymal Stem Cell Therapy May Help Slow, Repair Degenerative Signs of Osteoarthritis, Musculoskeletal Disease
  • Can Nasal Tissue Be Used to Repair a Damaged Knee Joint?

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.